OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.

Shareholder Tools

Latest News
OpGen to Provide Business Update and Financial Results for the Third Quarter 2021 on November 11th at 4:30 p.m. Eastern Time
OpGen Subsidiary Ares Genetics Launches AREScloud
OpGen Announces Closing of $15 Million Registered Direct Offering

btn News

See All News

Upcoming Events
11.11.21 at 4:30 PM EST
Q3 2021 OpGen, Inc. Earnings Conference Call MORE

btn Events

See all events